India
13 Vaccines Approved for Use in India
Protein Subunit
Serum Institute of India
COVOVAX (Novavax formulation)
Approved in 6 countries
7 trials in 3 countries
Approval Source: timesofindia.indiatimes.com
Protein Subunit
Biological E Limited
Corbevax
Approved in 2 countries
7 trials in 1 country
Approval Source: bbc.com
DNA
RNA
Non Replicating Viral Vector
Gamaleya
Sputnik Light
Approved in 26 countries
7 trials in 3 countries
Approval Source: hindustantimes.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: nytimes.com
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
6 trials in 1 country
Approval Source: cdsco.gov.in
Inactivated
RNA
Gennova Biopharmaceuticals Limited
GEMCOVAC-19
Approved in 1 country
2 trials in 1 country
Approval Source: hdt.bio
Non Replicating Viral Vector
Bharat Biotech
iNCOVACC
Approved in 1 country
4 trials in 1 country
Approval Source: bharatbiotech.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com
17 in Clinical Trials in India
Protein Subunit
Biological E Limited
Corbevax
Approved in 2 countries
7 trials in 1 country
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
Protein Subunit
Serum Institute of India
COVOVAX (Novavax formulation)
Approved in 6 countries
7 trials in 3 countries
Protein Subunit
University Medical Center Groningen
AKS-452
4 trials in 2 countries
DNA
Zydus Cadila
ZyCoV-D
Approved in 1 country
6 trials in 1 country
Non Replicating Viral Vector
Bharat Biotech
BBV154
2 trials in 1 country
Non Replicating Viral Vector
Gamaleya
Sputnik V
Approved in 74 countries
25 trials in 8 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
6 trials in 1 country
Inactivated
Bharat Biotech
Covaxin
Approved in 14 countries
16 trials in 2 countries
Protein Subunit
Biological E Limited
BECOV2B
2 trials in 1 country
Protein Subunit
Biological E Limited
BECOV2C
2 trials in 1 country
Protein Subunit
Biological E Limited
BECOV2D
2 trials in 1 country
RNA
Gennova Biopharmaceuticals Limited
HGCO19
2 trials in 1 country
RNA
Gennova Biopharmaceuticals Limited
GEMCOVAC-19
Approved in 1 country
2 trials in 1 country
Non Replicating Viral Vector
Gamaleya
Sputnik Light
Approved in 26 countries
7 trials in 3 countries
Non Replicating Viral Vector
Bharat Biotech
iNCOVACC
Approved in 1 country
4 trials in 1 country